Get started
Author

Kristina Riegel

Observed name: Riegel, Kristina
ORCID: 0000-0002-3656-8453
Observed ORCID: 0000-0002-3656-8453
OpenAlex ID: A5077615373
Druggable genome and precision medicine in cancer: current challenges
2021 · Camille Amandine Dupont, Kristina Riegel, et al. · FEBS Journal · 83
PDF
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression
2021 · Kristina Riegel, Hajime Yurugi, et al. · Cell Death and Disease · 31
PDF
RAF kinases are stabilized and required for dendritic cell differentiation and function
2019 · Kristina Riegel, Janine Schlöder, et al. · Cell Death and Differentiation · 27
PDF
Recent advances in targeting protein kinases and pseudokinases in cancer biology
2022 · Kristina Riegel, Parthiban Vijayarangakannan, et al. · Frontiers in Cell and Developmental Biology · 26
PDF
ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers
2022 · Juliane Mooz, Kristina Riegel, et al. · Science Advances · 17
Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Emilie Renaud, Kristina Riegel, et al. · Molecular Cancer · 10
PDF
Enhanced pro-apoptosis gene signature following the activation of TAp63α in oocytes upon γ irradiation
2022 · Niclas Fester, Elisabeth Zielonka, et al. · Cell Death and Disease · 9
PDF
L-Cystine-Containing Hair-Growth Formulation Supports Protection, Viability, and Proliferation of Keratinocytes
2020 · Kristina Riegel, Thomas Hengl, et al. · Clinical Cosmetic and Investigational Dermatology · 9
PDF
The non-linearity of RAF-MEK signaling in dendritic cells
2020 · Kristina Riegel, Krishnaraj Rajalingam · Cell Cycle · 8
PDF
Modulation of cellular transcriptome and proteome composition by azidohomoalanine—implications on click chemistry–based secretome analysis
2023 · Friederike Kirschner, Danielle Arnold-Schild, et al. · Journal of Molecular Medicine · 6
PDF
Regeneration of an Extracellular Matrix Ecosystem Following Subcutaneous Injection With Different Radiesse Dilutions: A Histologic and Ultrasound Study
2026 · Kate Goldie, Gabriela Casabona, et al. · Journal of Cosmetic Dermatology · 2
Direct Contact with CaHA Microspheres Drives ECM Stimulation In Vitro
2026 · Yoana Dimitrova, Cleiton Kunzler, et al. · Cosmetics
Abstract PO5-24-01: Narazaciclib’s differential targets and kinase inhibitory activity contribute to the enhanced inhibition of tumor growth in preclinical models
2024 · Petros Kechagioglou, Debomita Chakraborty, et al. · Cancer Research
Abstract A020: CETSA profiling unveils novel targets engaged by anti-tumor drug rigosertib to inhibit RAS-MAPK signaling and trigger NLRP3 inflammasome activation
2023 · Petros Kechagioglou, Camille Dupont, et al. · Molecular Cancer Research
Abstract 5987: Differential targets engaged by narazaciclib in comparison to the approved CDK4/6 inhibitors contribute to enhanced inhibition of tumor cell growth
2023 · Petros Kechagioglou, Camille Dupont, et al. · Cancer Research
Narazaciclib’s kinase inhibitory activity is differentiated from approved CDK4/6 inhibitors in preclinical models.
2022 · Petros Kechagioglou, Camille Dupont, et al. · Journal of Clinical Oncology
Additional file 3 of Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Renaud, Emilie, Riegel, Kristina, et al. · Figshare
Additional file 4 of Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Renaud, Emilie, Riegel, Kristina, et al. · Figshare
Additional file 2 of Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Renaud, Emilie, Riegel, Kristina, et al. · Figshare
Works count: 22
Citation count: 228
H-index: 8
I10-index: 6
Year
Topic
Type